| 0.987 | 0.002 | 0.987 | Dopamine antagonist | | |
| 0.984 | 0.002 | 0.984 | Dopamine D4 antagonist | | |
| 0.984 | 0.002 | 0.984 | Dopamine D2 antagonist | | |
| 0.978 | 0.002 | 0.978 | 5 Hydroxytryptamine antagonist | | |
| 0.973 | 0.001 | 0.973 | Dopamine D1 antagonist | | |
| 0.966 | 0.002 | 0.966 | 5 Hydroxytryptamine 2 antagonist | | |
| 0.956 | 0.002 | 0.956 | 5 Hydroxytryptamine 2C antagonist | | |
| 0.925 | 0.002 | 0.925 | 5 Hydroxytryptamine 2A antagonist | | |
| 0.884 | 0.002 | 0.884 | 5 Hydroxytryptamine 2B antagonist | | |
| 0.841 | 0.003 | 0.841 | 5 Hydroxytryptamine 1 antagonist | | |
| 0.83 | 0.003 | 0.83 | 5 Hydroxytryptamine 1A antagonist | | |
| 0.784 | 0.004 | 0.784 | Alpha adrenoreceptor antagonist | | |
| 0.753 | 0.003 | 0.753 | Alpha 1b adrenoreceptor antagonist | | |
| 0.753 | 0.008 | 0.753 | Antiobesity | | |
| 0.739 | 0.002 | 0.739 | Dopamine D3 antagonist | | |
| 0.736 | 0.002 | 0.736 | Dopamine D5 antagonist | | |
| 0.728 | 0.003 | 0.728 | Alpha 1 adrenoreceptor antagonist | | |
| 0.699 | 0.003 | 0.699 | Alpha 1a adrenoreceptor antagonist | | |
| 0.649 | 0.003 | 0.649 | Histamine H1 receptor antagonist | | |
| 0.593 | 0.004 | 0.593 | 5 Hydroxytryptamine agonist | | |
| 0.561 | 0.004 | 0.561 | 5 Hydroxytryptamine 1F antagonist | | |
| 0.521 | 0.003 | 0.521 | 5 Hydroxytryptamine 3 antagonist | | |
| 0.546 | 0.037 | 0.546 | Analgesic | | |
| 0.504 | 0.003 | 0.504 | 5 Hydroxytryptamine 5A antagonist | | |
| 0.501 | 0.004 | 0.501 | Alpha 2c adrenoreceptor antagonist | | |
| 0.502 | 0.012 | 0.502 | Anticonvulsant | | |
| 0.477 | 0.003 | 0.477 | 5 Hydroxytryptamine 5 antagonist | | |
| 0.457 | 0.005 | 0.457 | Histamine antagonist | | |
| 0.454 | 0.005 | 0.454 | Antihistaminic | | |
| 0.432 | 0.004 | 0.432 | Alpha 2a adrenoreceptor antagonist | | |
| 0.43 | 0.004 | 0.43 | Alpha 1d adrenoreceptor antagonist | | |
| 0.445 | 0.021 | 0.445 | HERG channel blocker | | |
| 0.405 | 0.005 | 0.405 | Alpha 2b adrenoreceptor antagonist | | |
| 0.386 | 0.005 | 0.386 | 5 Hydroxytryptamine 7 antagonist | | |
| 0.384 | 0.005 | 0.384 | Alpha 2 adrenoreceptor antagonist | | |
| 0.382 | 0.005 | 0.382 | 5 Hydroxytryptamine 1E antagonist | | |
| 0.399 | 0.023 | 0.399 | Potassium channel blocker | | |
| 0.383 | 0.009 | 0.383 | Cholinergic antagonist | | |
| 0.386 | 0.029 | 0.386 | Potassium channel (Voltage-sensitive) blocker | | |
| 0.359 | 0.009 | 0.359 | Acetylcholine antagonist | | |
| 0.374 | 0.046 | 0.374 | Nootropic | | |
| 0.33 | 0.004 | 0.33 | Dopamine uptake inhibitor | | |
| 0.326 | 0.012 | 0.326 | Antiadrenergic | | |
| 0.36 | 0.049 | 0.36 | Spasmolytic | | |
| 0.314 | 0.012 | 0.314 | Adrenaline antagonist | | |
| 0.302 | 0.009 | 0.302 | Acetylcholine muscarinic antagonist | | |
| 0.318 | 0.029 | 0.318 | Ca(v)3.3 blocker | | |
| 0.285 | 0.006 | 0.285 | Sigma receptor antagonist | | |
| 0.288 | 0.017 | 0.288 | Acetylcholine M1 receptor antagonist | | |
| 0.275 | 0.006 | 0.275 | 5 Hydroxytryptamine 1A agonist | | |
| 0.257 | 0.008 | 0.257 | 5 Hydroxytryptamine 1 agonist | | |
| 0.251 | 0.004 | 0.251 | 5 Hydroxytryptamine 2C agonist | | |
| 0.268 | 0.024 | 0.268 | Cholinergic | | |
| 0.243 | 0.006 | 0.243 | 5 Hydroxytryptamine 3A agonist | | |
| 0.245 | 0.009 | 0.245 | Acetylcholine agonist | | |
| 0.316 | 0.089 | 0.316 | Vasodilator, peripheral | | |
| 0.231 | 0.004 | 0.231 | Acetylcholine M5 receptor antagonist | | |
| 0.232 | 0.007 | 0.232 | 5 Hydroxytryptamine 1B antagonist | | |
| 0.226 | 0.004 | 0.226 | 5 Hydroxytryptamine 3A antagonist | | |
| 0.231 | 0.009 | 0.231 | 5 Hydroxytryptamine uptake inhibitor | | |
| 0.215 | 0.004 | 0.215 | 5 Hydroxytryptamine 2A agonist | | |
| 0.22 | 0.008 | 0.22 | Dopamine agonist | | |
| 0.212 | 0.006 | 0.212 | 5 Hydroxytryptamine 1D antagonist | | |
| 0.208 | 0.004 | 0.208 | CC chemokine 3 receptor antagonist | | |
| 0.246 | 0.049 | 0.246 | Sigma receptor agonist | | |
| 0.216 | 0.02 | 0.216 | Nav1.3 sodium channel blocker | | |
| 0.201 | 0.013 | 0.201 | Acetylcholine nicotinic antagonist | | |
| 0.204 | 0.018 | 0.204 | Nav1.1 sodium channel blocker | | |
| 0.189 | 0.005 | 0.189 | Nicotinic alpha4beta2 receptor antagonist | | |
| 0.185 | 0.009 | 0.185 | Acetylcholine nicotinic agonist | | |
| 0.178 | 0.007 | 0.178 | Alpha 1 adrenoreceptor agonist | | |
| 0.184 | 0.026 | 0.184 | Nav1.6 sodium channel blocker | | |
| 0.169 | 0.01 | 0.169 | Neuronal nicotinic receptor antagonist | | |
| 0.189 | 0.039 | 0.189 | Nav1.2 sodium channel blocker | | |
| 0.157 | 0.009 | 0.157 | Dopamine D4 agonist | | |
| 0.251 | 0.105 | 0.251 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | | |
| 0.153 | 0.01 | 0.153 | Acetylcholine M4 receptor antagonist | | |
| 0.146 | 0.005 | 0.146 | 5 Hydroxytryptamine 2 agonist | | |
| 0.127 | 0.008 | 0.127 | Nicotinic receptor alpha3 subunit antagonist | | |
| 0.123 | 0.004 | 0.123 | 5 Hydroxytryptamine 4 antagonist | | |
| 0.15 | 0.032 | 0.15 | Chemokine receptor antagonist | | |
| 0.163 | 0.049 | 0.163 | Calcium channel blocker | | |
| 0.123 | 0.01 | 0.123 | Acetylcholine M5 receptor agonist | | |
| 0.134 | 0.022 | 0.134 | Glutamate receptor agonist | | |
| 0.125 | 0.013 | 0.125 | Acetylcholine muscarinic agonist | | |
| 0.121 | 0.009 | 0.121 | Nicotinic neuronal receptor agonist | | |
| 0.128 | 0.017 | 0.128 | Histamine H2 receptor antagonist | | |
| 0.118 | 0.01 | 0.118 | 5 Hydroxytryptamine 6 antagonist | | |
| 0.129 | 0.023 | 0.129 | CC chemokine receptor antagonist | | |
| 0.182 | 0.078 | 0.182 | P-glycoprotein inhibitor | | |
| 0.108 | 0.008 | 0.108 | Nicotinic alpha7 receptor agonist | | |
| 0.109 | 0.011 | 0.109 | Nicotinic receptor alpha7 subunit antagonist | | |
| 0.108 | 0.012 | 0.108 | 5 Hydroxytryptamine 3 agonist | | |
| 0.236 | 0.141 | 0.236 | Apoptosis antagonist | | |
| 0.217 | 0.122 | 0.217 | 5 Hydroxytryptamine uptake stimulant | | |
| 0.144 | 0.06 | 0.144 | Toll-Like receptor antagonist | | |
| 0.122 | 0.042 | 0.122 | Toll-Like receptor 4 antagonist | | |
| 0.098 | 0.019 | 0.098 | Adrenaline uptake inhibitor | | |
| 0.199 | 0.125 | 0.199 | DNA synthesis inhibitor | | |
| 0.077 | 0.005 | 0.077 | Sigma 2 receptor antagonist | | |
| 0.075 | 0.008 | 0.075 | 5 Hydroxytryptamine 3B antagonist | | |
| 0.08 | 0.014 | 0.08 | Dopamine D2 agonist | | |
| 0.092 | 0.029 | 0.092 | Calcium channel L-type blocker | | |
| 0.08 | 0.016 | 0.08 | Acetylcholine M1 receptor agonist | | |
| 0.093 | 0.031 | 0.093 | Alpha adrenoreceptor agonist | | |
| 0.077 | 0.015 | 0.077 | 5 Hydroxytryptamine 7 agonist | | |
| 0.191 | 0.129 | 0.191 | 5 Hydroxytryptamine release stimulant | | |
| 0.078 | 0.018 | 0.078 | Dopamine transporter inhibitor | | |
| 0.077 | 0.017 | 0.077 | Histamine H3 receptor antagonist | | |
| 0.102 | 0.044 | 0.102 | Acetylcholine M3 receptor agonist | | |
| 0.141 | 0.083 | 0.141 | NOS3 expression enhancer | | |
| 0.081 | 0.029 | 0.081 | Acetylcholine M2 receptor antagonist | | |
| 0.066 | 0.018 | 0.066 | Nicotinic receptor alpha4 subunit antagonist | | |
| 0.075 | 0.028 | 0.075 | Acetylcholine M3 receptor antagonist | | |
| 0.067 | 0.021 | 0.067 | Neurokinin antagonist | | |
| 0.059 | 0.014 | 0.059 | Dopamine D3 agonist | | |
| 0.095 | 0.052 | 0.095 | Opioid antagonist | | |
| 0.057 | 0.016 | 0.057 | Neurokinin 1 antagonist | | |
| 0.11 | 0.069 | 0.11 | Calcium channel (voltage-sensitive) blocker | | |
| 0.064 | 0.024 | 0.064 | Acetylcholine M2 receptor agonist | | |
| 0.083 | 0.044 | 0.083 | Viral attachment inhibitor | | |
| 0.077 | 0.04 | 0.077 | Phospholipase D inhibitor | | |
| 0.06 | 0.026 | 0.06 | CC chemokine 5 receptor antagonist | | |
| 0.059 | 0.028 | 0.059 | Nicotinic alpha3beta2 receptor antagonist | | |
| 0.068 | 0.038 | 0.068 | Glutamate (mGluR) agonist | | |
| 0.064 | 0.036 | 0.064 | Prolactin release inhibitor | | |
| 0.046 | 0.017 | 0.046 | Nociceptin (N/OFQ) receptor antagonist | | |
| 0.198 | 0.171 | 0.198 | Ca2+/calmodulin-dependent kinase IV inhibitor | | |
| 0.081 | 0.056 | 0.081 | Opioid kappa receptor antagonist | | |
| 0.111 | 0.087 | 0.111 | Acetylcholinesterase inhibitor | | |
| 0.037 | 0.014 | 0.037 | Sigma 1 receptor antagonist | | |
| 0.057 | 0.033 | 0.057 | Melanin-concentrating hormone receptor 1 antagonist | | |
| 0.044 | 0.022 | 0.044 | Substance P antagonist | | |
| 0.171 | 0.15 | 0.171 | Cardiotonic | | |
| 0.062 | 0.052 | 0.062 | Opioid mu receptor antagonist | | |
| 0.026 | 0.016 | 0.026 | 5 Hydroxytryptamine 1F agonist | | |
| 0.183 | 0.175 | 0.183 | Gastrin inhibitor | | |
| 0.034 | 0.027 | 0.034 | Adenosine uptake inhibitor | | |
| 0.024 | 0.019 | 0.024 | 5 Hydroxytryptamine 4 agonist | | |
| 0.036 | 0.033 | 0.036 | 5 Hydroxytryptamine 2B agonist | | |
| 0.031 | 0.029 | 0.031 | Glutamate (mGluR group II) agonist | | |
| 0.041 | 0.039 | 0.041 | Poly(ADP-ribose) polymerase inhibitor | | |
| 0.028 | 0.027 | 0.028 | Glutamate (mGluR2) agonist | | |